GB2324093A
(en)
|
1996-01-04 |
1998-10-14 |
Rican Limited |
Helicobacter pylori bacterioferritin
|
US5882892A
(en)
*
|
1997-07-23 |
1999-03-16 |
Smithkline Beecham Corporation |
Asps
|
US6001602A
(en)
|
1997-07-23 |
1999-12-14 |
Smithkline Beecham Corporation |
DNA encoding Chlamydia trachomatis isoleucyl tRNA synthetase polypeptides
|
WO1999028475A2
(en)
*
|
1997-11-28 |
1999-06-10 |
Genset |
Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
|
AU4793199A
(en)
*
|
1998-07-27 |
2000-02-21 |
Aventis Pasteur Limited |
(chlamydia) antigens and corresponding dna fragments and uses thereof
|
EP1108033A2
(de)
*
|
1998-07-27 |
2001-06-20 |
Aventis Pasteur Limited |
Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen
|
WO2000006739A2
(en)
*
|
1998-07-27 |
2000-02-10 |
Connaught Laboratories Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
US20030147924A1
(en)
*
|
1998-07-27 |
2003-08-07 |
Aventis Pasteur Limited/Aventis Pasteur Limitee |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
US6660275B2
(en)
*
|
1998-07-27 |
2003-12-09 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
JP2002523049A
(ja)
*
|
1998-08-20 |
2002-07-30 |
コナート ラボラトリーズ リミテッド |
Chlamydia抗原および対応するDNAフラグメントおよびそれらの使用
|
CA2340283A1
(en)
*
|
1998-08-20 |
2000-03-02 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding pomp91a protein of chlamydia
|
US6686339B1
(en)
|
1998-08-20 |
2004-02-03 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
|
US6693087B1
(en)
|
1998-08-20 |
2004-02-17 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding POMP91A protein of Chlamydia
|
EP1105490A1
(de)
|
1998-08-20 |
2001-06-13 |
Aventis Pasteur Limited |
Einschlussmembranprotein c von chlamydia kodierende nukleinsäuremoleküle
|
US6649370B1
(en)
*
|
1998-10-28 |
2003-11-18 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
EP1129202A2
(de)
*
|
1998-10-28 |
2001-09-05 |
Aventis Pasteur Limited |
Chlamydia polypeptiden und entspechende dna fragmenten und anwendungen davon
|
US6403101B1
(en)
|
1998-10-28 |
2002-06-11 |
Connaught Laboratories Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6872814B2
(en)
|
1998-10-29 |
2005-03-29 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6403102B1
(en)
|
1998-10-29 |
2002-06-11 |
Connaught Laboratories Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6607730B1
(en)
|
1998-11-02 |
2003-08-19 |
Aventis Pasteur Limited/Aventis Pasteur Limitee |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6822071B1
(en)
*
|
1998-11-12 |
2004-11-23 |
The Regents Of The University Of California |
Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
|
WO2000032794A2
(en)
*
|
1998-12-01 |
2000-06-08 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
JP2002531093A
(ja)
|
1998-12-01 |
2002-09-24 |
アベンティス、パストゥール、リミテッド |
クラミジア抗原および対応するdna断片ならびにその使用
|
US6565856B1
(en)
|
1998-12-08 |
2003-05-20 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6448234B1
(en)
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
HUP0400719A3
(en)
|
1998-12-08 |
2010-08-30 |
Corixa Corp |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6555115B1
(en)
|
1998-12-08 |
2003-04-29 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6447779B1
(en)
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds for the diagnosis of Chlamydial infection
|
US20020061848A1
(en)
|
2000-07-20 |
2002-05-23 |
Ajay Bhatia |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6432916B1
(en)
|
1998-12-08 |
2002-08-13 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
EP1140999A1
(de)
|
1998-12-23 |
2001-10-10 |
Aventis Pasteur Limited |
Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen
|
US7297341B1
(en)
|
1998-12-23 |
2007-11-20 |
Sanofi Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
ATE384738T1
(de)
*
|
1998-12-28 |
2008-02-15 |
Aventis Pasteur |
Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen
|
US6808713B1
(en)
|
1998-12-28 |
2004-10-26 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
GB9902555D0
(en)
|
1999-02-05 |
1999-03-24 |
Neutec Pharma Plc |
Medicament
|
NZ514140A
(en)
|
1999-03-12 |
2001-09-28 |
Aventis Pasteur |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
JP4695763B2
(ja)
*
|
1999-05-03 |
2011-06-08 |
サノフィ、パストゥール、リミテッド |
クラミジア抗原および対応するdna断片ならびにその使用
|
AU5668500A
(en)
*
|
1999-06-30 |
2001-01-22 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
AU7398300A
(en)
*
|
1999-09-17 |
2001-04-24 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
WO2001021810A1
(en)
*
|
1999-09-17 |
2001-03-29 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
AU7398400A
(en)
*
|
1999-09-17 |
2001-04-24 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
AU7398600A
(en)
*
|
1999-09-17 |
2001-04-24 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
WO2001021806A1
(en)
*
|
1999-09-17 |
2001-03-29 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
ATE384793T1
(de)
*
|
1999-09-20 |
2008-02-15 |
Aventis Pasteur |
Chlamydia antigene und entsprechende dna- fragmente und ihre verwendungen
|
US6632663B1
(en)
|
1999-09-22 |
2003-10-14 |
Aventis Pasteur Limited |
DNA immunization against chlamydia infection
|
AU7732000A
(en)
*
|
1999-09-29 |
2001-04-30 |
Mara Diaz |
Method of identifying pathogenic cryptococci
|
DK1094069T4
(da)
*
|
1999-10-18 |
2008-07-21 |
Intervet Int Bv |
DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf
|
AU1375501A
(en)
*
|
1999-11-12 |
2001-05-30 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
AU1375601A
(en)
*
|
1999-11-15 |
2001-05-30 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
AU1375701A
(en)
*
|
1999-11-15 |
2001-05-30 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
DE19959650A1
(de)
*
|
1999-12-10 |
2001-06-13 |
Degussa |
Neue für die Gene sdhA, sdhB und sdhC codierende Nukleotidsequenzen
|
CA2395499C
(en)
*
|
1999-12-22 |
2011-10-25 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
WO2001046225A2
(en)
*
|
1999-12-22 |
2001-06-28 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
AU2138601A
(en)
*
|
1999-12-22 |
2001-07-03 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
CN1962694A
(zh)
*
|
2000-01-31 |
2007-05-16 |
旭化成株式会社 |
肺炎衣原体检测用抗体
|
US20020082402A1
(en)
*
|
2000-04-04 |
2002-06-27 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US20030100706A1
(en)
*
|
2000-04-04 |
2003-05-29 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US20020071831A1
(en)
|
2000-04-04 |
2002-06-13 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US20020132994A1
(en)
*
|
2000-04-04 |
2002-09-19 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US20020094965A1
(en)
*
|
2000-04-04 |
2002-07-18 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6919187B2
(en)
|
2000-04-21 |
2005-07-19 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
EP2192128A3
(de)
|
2000-04-21 |
2010-09-22 |
Corixa Corporation |
Verbindungen und Verfahren zur Behandlung und Diagnose von Chlamydia-Infektionen
|
ATE348892T1
(de)
*
|
2000-05-08 |
2007-01-15 |
Sanofi Pasteur Ltd |
Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
|
EP1792995A3
(de)
|
2000-05-08 |
2007-06-13 |
Sanofi Pasteur Limited |
Chlamydia Antigene, entsprechende DNS Fragmente und ihre Verwendungen
|
US20040005667A1
(en)
|
2000-07-03 |
2004-01-08 |
Giuloi Ratti |
Immunisation against chlamydia pneumoniae
|
AUPQ954000A0
(en)
*
|
2000-08-18 |
2000-09-14 |
Queensland University Of Technology |
Novel diagnostic agents and uses therefor
|
US6539102B1
(en)
|
2000-09-01 |
2003-03-25 |
Large Scale Proteomics |
Reference database
|
US6980674B2
(en)
|
2000-09-01 |
2005-12-27 |
Large Scale Proteomics Corp. |
Reference database
|
US7537772B1
(en)
*
|
2000-10-02 |
2009-05-26 |
Emergent Product Development Gaithersburg Inc. |
Chlamydia protein, gene sequence and the uses thereof
|
US7731980B2
(en)
|
2000-10-02 |
2010-06-08 |
Emergent Product Development Gaithersburg Inc. |
Chlamydia PMP proteins, gene sequences and uses thereof
|
MX357775B
(es)
|
2000-10-27 |
2018-07-20 |
J Craig Venter Inst Inc |
Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
|
US6682889B1
(en)
|
2000-11-08 |
2004-01-27 |
Becton, Dickinson And Company |
Amplification and detection of organisms of the Chlamydiaceae family
|
US20070149474A1
(en)
*
|
2000-12-15 |
2007-06-28 |
Auburn University |
Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
|
US20030059896A1
(en)
*
|
2000-12-21 |
2003-03-27 |
Shire Biochem Inc. |
Novel chlamydia antigens and corresponding DNA fragments
|
GB0102929D0
(en)
*
|
2001-02-06 |
2001-03-21 |
Inpharmatica Ltd |
Novel proteins
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
MXPA03009222A
(es)
*
|
2001-04-09 |
2004-11-12 |
Allan Christian Shaw |
Metodo para la identificacion de proteinas a partir de bacterias intracelulares.
|
US6891085B2
(en)
*
|
2001-04-20 |
2005-05-10 |
Pioneer Hi-Bred International, Inc. |
Nucleic acid encoding the FUS6 antimicrobial polypeptide of Agrotis ipsilon and its use to enhance disease resistance in a plant
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
ATE406912T1
(de)
|
2001-12-12 |
2008-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia tracheomatis
|
GB0203403D0
(en)
|
2002-02-13 |
2002-04-03 |
Chiron Spa |
Chlamydia cytotoxic-T cell epitopes
|
US7501134B2
(en)
|
2002-02-20 |
2009-03-10 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticles with adsorbed polypeptide-containing molecules
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
LT2395073T
(lt)
|
2002-11-01 |
2017-11-10 |
Glaxosmithkline Biologicals S.A. |
Džiovinimo būdas
|
AU2003288660A1
(en)
|
2002-11-15 |
2004-06-15 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
KR100532665B1
(ko)
*
|
2002-11-28 |
2005-12-02 |
주식회사 바이오메드랩 |
나이세리아속 균 탐지용 프로브, 이를 이용한나이세리아속 균의 유전형 분석키트 및 유전형 분석방법
|
EP1585542B1
(de)
|
2002-12-27 |
2012-06-13 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogene zusammensetzungen enthaltend phospholipid
|
US20070003568A1
(en)
*
|
2003-02-24 |
2007-01-04 |
Alice Dautry-Varsat |
Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
|
EP1608369B1
(de)
|
2003-03-28 |
2013-06-26 |
Novartis Vaccines and Diagnostics, Inc. |
Verwendung von organischen verbindungen zur immunpotenzierung
|
WO2004087924A2
(en)
*
|
2003-03-31 |
2004-10-14 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Method for delivery of substances to intracellular microorganisms
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
ATE437633T2
(de)
|
2003-06-02 |
2009-08-15 |
Novartis Vaccines & Diagnostic |
Immunogene zusammensetzungen auf basis von biologisch abbaubaren mikroteilchen enthaltend ein diphtherie- und ein tetanustoxoid
|
US20110104186A1
(en)
|
2004-06-24 |
2011-05-05 |
Nicholas Valiante |
Small molecule immunopotentiators and assays for their detection
|
JP2008504292A
(ja)
|
2004-06-24 |
2008-02-14 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド |
免疫増強用の化合物
|
US20060165716A1
(en)
|
2004-07-29 |
2006-07-27 |
Telford John L |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
SI1812058T1
(sl)
|
2004-10-25 |
2013-02-28 |
Statens Serum Institut |
Antigeni chlamidia trachomatis za cepivo in diagnostiäśno rabo
|
GB0424092D0
(en)
|
2004-10-29 |
2004-12-01 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
GB0502095D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Conjugation of streptococcal capsular saccharides
|
GB0502096D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Purification of streptococcal capsular polysaccharide
|
WO2006089264A2
(en)
|
2005-02-18 |
2006-08-24 |
Novartis Vaccines And Diagnostics Inc. |
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
|
CN101180312A
(zh)
|
2005-02-18 |
2008-05-14 |
诺华疫苗和诊断公司 |
来自尿路病原性大肠杆菌的免疫原
|
JP2006273805A
(ja)
*
|
2005-03-30 |
2006-10-12 |
Yamaguchi Univ |
肺炎クラミジアのIncA2蛋白質、クラミジアのInc蛋白質群およびその利用方法
|
US8541007B2
(en)
|
2005-03-31 |
2013-09-24 |
Glaxosmithkline Biologicals S.A. |
Vaccines against chlamydial infection
|
AU2006254891B2
(en)
|
2005-06-06 |
2011-04-14 |
Gen-Probe Incorporated |
Compositions, methods and kits for determining the presence of Chlamydophila pneumoniae in a test sample
|
US20110223197A1
(en)
|
2005-10-18 |
2011-09-15 |
Novartis Vaccines And Diagnostics Inc. |
Mucosal and Systemic Immunization with Alphavirus Replicon Particles
|
JP5215865B2
(ja)
|
2005-11-22 |
2013-06-19 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド |
ノロウイルス抗原およびサポウイルス抗原
|
DE102006003814A1
(de)
*
|
2006-01-26 |
2007-08-02 |
Sirs-Lab Gmbh |
Verfahren zur in-vitro-Diagnose von Chlamydophila pneumoniae Infektionen
|
CA2646539A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Imidazoquinoxaline compounds as immunomodulators
|
US20100166788A1
(en)
|
2006-08-16 |
2010-07-01 |
Novartis Vaccines And Diagnostics |
Immunogens from uropathogenic escherichia coli
|
US20080160027A1
(en)
*
|
2006-12-04 |
2008-07-03 |
Kathryn Frances Sykes |
Chlamydia pneumoniae vaccine and methods for administering such a vaccine
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
US20100203075A1
(en)
*
|
2007-06-18 |
2010-08-12 |
Intercell Ag |
Chlamydia antigens
|
AU2008299376B2
(en)
|
2007-09-12 |
2013-02-28 |
Glaxosmithkline Biologicals S.A. |
GAS57 mutant antigens and GAS57 antibodies
|
US8637053B2
(en)
|
2007-12-03 |
2014-01-28 |
President And Fellows Of Harvard College |
Chlamydia antigens
|
KR101773114B1
(ko)
|
2007-12-21 |
2017-08-30 |
노파르티스 아게 |
스트렙토라이신 o의 돌연변이 형태
|
WO2009120995A2
(en)
|
2008-03-27 |
2009-10-01 |
Purdue Research Foundation |
Collagen-binding synthetic peptidoglycans, preparation, and methods of use
|
HUE029265T2
(en)
|
2008-10-27 |
2017-02-28 |
Glaxosmithkline Biologicals Sa |
Method of purifying carbohydrates from the group streptococci
|
US8425922B2
(en)
|
2009-01-05 |
2013-04-23 |
EpitoGenesis, Inc. |
Adjuvant compositions and methods of use
|
AU2010204139A1
(en)
|
2009-01-12 |
2011-08-11 |
Novartis Ag |
Cna_B domain antigens in vaccines against gram positive bacteria
|
EP2403526B1
(de)
|
2009-03-06 |
2019-05-15 |
GlaxoSmithKline Biologicals SA |
Chlamydia-antigene
|
CA2779798C
(en)
|
2009-09-30 |
2019-03-19 |
Novartis Ag |
Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides
|
CN102971009A
(zh)
|
2009-10-30 |
2013-03-13 |
诺华有限公司 |
金黄色葡萄球菌5型和8型荚膜多糖的纯化
|
AU2011243039B2
(en)
*
|
2010-04-16 |
2015-01-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Real time PCR assay for detection of bacterial respiratory pathogens
|
WO2011149564A1
(en)
|
2010-05-28 |
2011-12-01 |
Tetris Online, Inc. |
Interactive hybrid asynchronous computer game infrastructure
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
CA2860331A1
(en)
|
2010-12-24 |
2012-06-28 |
Novartis Ag |
Compounds
|
ES2708076T3
(es)
|
2011-05-24 |
2019-04-08 |
Symic Ip Llc |
Peptidoglicanos sintéticos que se unen al ácido hialurónico, preparación y métodos de uso
|
CN107837394A
(zh)
|
2011-06-24 |
2018-03-27 |
埃皮托吉尼西斯有限公司 |
作为抗原特异性免疫调节剂的包含选择的载体、维生素、单宁和类黄酮的组合的药物组合物
|
EP2755683B1
(de)
|
2011-09-14 |
2019-04-03 |
GlaxoSmithKline Biologicals SA |
Verfahren zur herstellung von saccharidprotein-glykokonjugaten
|
MX354924B
(es)
|
2011-11-07 |
2018-03-22 |
Novartis Ag |
Molecula portadora que comprende un antigeno spr0096 y un spr2021.
|
WO2013174832A1
(en)
|
2012-05-22 |
2013-11-28 |
Novartis Ag |
Meningococcus serogroup x conjugate
|
JP6603650B2
(ja)
|
2013-03-15 |
2019-11-06 |
パーデュー・リサーチ・ファウンデーション |
細胞外マトリックス結合性合成ペプチドグリカン
|
US10835594B2
(en)
*
|
2014-01-16 |
2020-11-17 |
Mcmaster University |
Type III secretion injectisome proteins for treatment and prevention of chlamydial infections
|
US10772931B2
(en)
|
2014-04-25 |
2020-09-15 |
Purdue Research Foundation |
Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
|
US11612664B2
(en)
|
2016-04-05 |
2023-03-28 |
Gsk Vaccines S.R.L. |
Immunogenic compositions
|
KR20200026263A
(ko)
|
2017-07-07 |
2020-03-10 |
시믹 아이피, 엘엘씨 |
합성 생체접합체
|
CN108875000B
(zh)
*
|
2018-06-14 |
2021-12-28 |
广东工业大学 |
一种融合多句法结构的语义关系分类方法
|
CN109180822B
(zh)
*
|
2018-11-14 |
2021-08-10 |
上海交通大学 |
一种猪链球菌b细胞优势表位串联疫苗及其制备方法
|
KR102422293B1
(ko)
*
|
2020-08-24 |
2022-07-18 |
수원대학교산학협력단 |
Erm 단백질과 상호작용하는 Helix 73 유래 RNA 분자 및 이의 이용 방법
|
CN112119907A
(zh)
*
|
2020-09-21 |
2020-12-25 |
连云港市农业科学院 |
一种洋葱全不育制种方法
|
CN114137209B
(zh)
*
|
2021-02-01 |
2024-03-01 |
中国水产科学研究院黄海水产研究所 |
一种快速检测牡蛎疱疹病毒抗原的免疫荧光检测试纸条及应用
|